Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-Dose Pylera Regimen for H. Pylori Infection
NCT02045251Phase 4Withdrawn
- Sponsor
- American University of Beirut Medical Center
- Start
- Jun 2013
- Primary completion
- Jul 2016
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride in Helicobacter pylori infection, sponsored by American University of Beirut Medical Center. Planned start Jun 2013; status: withdrawn.
02
Drugs
bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02045251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02045251.